Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register .
Joana S Carvalho,Edgard T Dos Reis Neto,Adriana M Kakehasi,Sandra LE Ribeiro,Samia As Studart,Francielle P Martins,Rafaela Cavalheiro do Espírito Santo,Aline Ranzolin,Diana C Fernandino,Valquiria G Dinis,Emília I Sato,Gustavo G Resende,Adriana Marinho,Henrique A Mariz,Nathália C Sacilotto,Francinne M Ribeiro,Samuel K Shinjo,Laiza H Dias,Michel A Yazbek,Felipe Omura,Thiago Hs Rached,Ana Paula M Gomides,Claudia Dl Marques,Gecilmara Cs Pillegi,Lícia Mh Mota,Marcelo M Pinheiro,Odirlei A Monticielo,Ricardo M Xavier,Gilda A Ferreira Lupus（2023）
摘要
Hypertension and cyclophosphamide were associated with a severe outcome, and telemedicine can be a useful tool for SLE patients with COVID-19.
更多查看译文
关键词
COVID-19,SARS-CoV-2,hospitalization,systemic lupus erythematosus
AI 理解论文
溯源树
样例
